Latest Drug Approvals news
FDA Approves Noninvasive Optune Pax Device for Advanced Pancreatic Cancer
posted February 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Quadruplet Regimen for Adults With Newly Diagnosed Multiple Myeloma
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Myqorzo for Symptomatic Obstructive Hypertrophic Cardiomyopathy
posted January 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
